Editorial: Sex and gender differences in cardiovascular-renal physiology and pathophysiology

Steroids

Volumn 75, Issue 11, 2010, Pages 745-746

  Reckelhoff, Jane F ^a,b   Maric, Christine ^b  

^a Women's Health Research Center   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; ESTROGEN RECEPTOR; SODIUM CHANNEL;

BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; DIABETES MELLITUS; EDITORIAL; HORMONE SUBSTITUTION; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; POSTMENOPAUSE; SEX DIFFERENCE; SODIUM ABSORPTION; SRY GENE; TARGET ORGAN; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; KIDNEY; KIDNEY DISEASE; MALE; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; ESTROGENS; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; SEX CHARACTERISTICS;

EID: 77955926928     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.05.020     Document Type: Editorial

References (15)

1. J.E. Manson, J. Hsia, K.C. Johnson, J.E. Rossouw, A.R. Assaf, and N.L. Lasser Estrogen plus progestin and the risk of coronary heart disease New Engl J Med 349 2003 523 534
2. D.M. Herrington The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study Ann Int Med 131 1999 463 466
3. D. Grady, D. Herrington, V. Bittner, R. Blumenthal, M. Davidson, and M. Hlatky Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
4. F. Naftolin, H.S. Taylor, R. Karas, E. Brinton, I. Newman, and T.B. Clarkson The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition Fertil Steril 81 2004 1498 1501
5. P.Y. Liu, A.K. Death, and D.J. Handelsman Androgens and cardiovascular disease Endocr Rev 24 2003 313 340
6. J.F. Reckelhoff, and L.A. Fortepiani Novel mechanisms responsible for postmenopausal hypertension Hypertension 43 2004 918 923
7. M.-J. Chen, W.-S. Yang, J.-H. Yang, C.L. Chen, H.N. Ho, and Y.S. Yang Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome Hypertension 49 2007 1442 1447
8. T.M. Musselman, Z. Zhang, and F.S. Masilamani Differential regulation of the bumetanide-sensitive contransporter (NKCC2) by ovarian hormones Steroids 75 2010 760 765
9. D. Ely, A. Underwood, G. Dunphy, S. Boehme, M. Turner, and A. Milsted Review of the Y Chromosome Sry and hypertension. Steroids 75 2010 747 753
10. M. Venegas-Pont, and M.J. Ryan Can estrogens promote hypertension during systemic lupus erythematosus? Steroids 75 2010 766 771
11. J.C. Sartori-Valinotti, M.R. Venegas-Pont, B.B. Lamarca, D.G. Romero, L.L. Yanes, and L.C. Racusen Rosiglitazone reduces blood pressure in female dahl salt-sensitive rats Steroids 75 2010 794 799
12. C. Maric, C. Forsblom, L. Thorn, J. Waden, P.H. Groop, and on behalf of the Finn-Diane Study Group. Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy Steroids 75 2010 772 778
13. A. Prabhu, Q. Xu, M.B. Manigrasso, M. Biswas, E. Flynn, and R. Iliescu Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes Steroids 75 2010 779 787
14. R. White Estrogen and oxidative stress: a novel mechanism that may increase the risk for cardiovascular disease in women Steroids 75 2010 788 793
15. J. Cheng, and P. Hurn Sex shapes experimental ischemic brain injury Steroids 75 2010 754 759